Jane Street’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-12,535
Closed -$2.22M 7819
2020
Q1
$2.22M Buy
12,535
+10,976
+704% +$2.07M ﹤0.01% 1921
2019
Q4
$298K Sell
1,559
-28,488
-95% -$5.14M ﹤0.01% 4283
2019
Q3
$5.06M Sell
30,047
-192,682
-87% -$31.4M 0.01% 985
2019
Q2
$37.3M Buy
222,729
+163,382
+275% +$22.6M 0.07% 220
2019
Q1
$8.69M Buy
59,347
+1,281
+2% +$186K 0.01% 772
2018
Q4
$7.76M Buy
58,066
+39,724
+217% +$6.51M 0.02% 707
2018
Q3
$3.49M Sell
18,342
-5,963
-25% -$1.1M 0.01% 1348
2018
Q2
$4.05M Sell
24,305
-13,535
-36% -$2.17M 0.01% 1232
2018
Q1
$6.37M Sell
37,840
-26,868
-42% -$4.51M 0.02% 801
2017
Q4
$10.6M Sell
64,708
-36,247
-36% -$6.5M 0.03% 489
2017
Q3
$20.7M Buy
100,955
+64,813
+179% +$15.1M 0.07% 266
2017
Q2
$8.79M Buy
36,142
+21,171
+141% +$4.97M 0.03% 514
2017
Q1
$3.58M Sell
14,971
-53,331
-78% -$12.4M 0.02% 924
2016
Q4
$14.3M Buy
68,302
+42,851
+168% +$8.88M 0.06% 242
2016
Q3
$5.86M Sell
25,451
-1,922
-7% -$470K 0.03% 523
2016
Q2
$6.33M Buy
27,373
+25,733
+1,569% +$5.93M 0.03% 525
2016
Q1
$440K Sell
1,640
-25,006
-94% -$7.16M ﹤0.01% 2746
2015
Q4
$8.33M Buy
26,646
+14,368
+117% +$4.28M 0.05% 318
2015
Q3
$3.34M Sell
12,278
-7,551
-38% -$2.32M 0.02% 635
2015
Q2
$6.02M Sell
19,829
-12,771
-39% -$3.81M 0.04% 389
2015
Q1
$9.7M Buy
32,600
+29,694
+1,022% +$8.47M 0.08% 228
2014
Q4
$748K Sell
2,906
-268
-8% -$67K 0.01% 1226
2014
Q3
$766K Buy
3,174
+115
+4% +$25.7K 0.01% 1109
2014
Q2
$682K Buy
3,059
+56
+2% +$11.6K 0.01% 1182
2014
Q1
$618K Sell
3,003
-8,551
-74% -$1.69M 0.01% 1375
2013
Q4
$1.94M Sell
11,554
-20,634
-64% -$3.23M 0.03% 486
2013
Q3
$4.63M Buy
32,188
+15,619
+94% +$2.08M 0.06% 257
2013
Q2
$2.09M Buy
+16,569
New +$1.88M 0.04% 449

Other funds holding AGN

Jane Street's AGN Position: Q2 2020 in Review

Jane Street sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 12,535 shares — an estimated $2.22M sold.

Jane Street first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $37.3M in Q2 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Jane Street reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Jane Street sold 12,535 Allergan plc shares in Q2 2020, an estimated $2.22M.
  • Jane Street first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Jane Street's Allergan plc position peaked at $37.3M in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Jane Street's 13F filing for Q2 2020, filed 17 Aug 2020.